Mayne Pharma Group Ltd
ASX:MYX
Mayne Pharma Group Ltd
ASX:MYX
Price:
7.24
AUD
-0.28%
Market Closed
Market Cap:
588.3m
AUD
Section:
Wall Street
Price Targets
Price Target
Average
+124%
Revenue
Forecast
N/A
Operating Income
Forecast
-14%
Net Income
Forecast
+12%
Wall Street
Price Targets
MYX Price Targets Summary
Mayne Pharma Group Ltd
Mayne Pharma Group Ltd
Wall Street analysts forecast MYX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
MYX
is 7.55 AUD
with a low forecast of 7.47 AUD and a high forecast of 7.77 AUD.
Lowest
Price Target
7.47
AUD
3% Upside
Average
Price Target
7.55
AUD
4% Upside
Highest
Price Target
7.77
AUD
7% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MYX's stock price target?
Price Target
7.55
AUD
7.55
AUD
According to Wall Street analysts, the average 1-year price target for
MYX
is 7.55 AUD
with a low forecast of 7.47 AUD and a high forecast of 7.77 AUD.
What is Mayne Pharma Group Ltd's Revenue forecast?
Projected CAGR
10%
10%
For the last 6 years the
compound annual growth rate for
Mayne Pharma Group Ltd's revenue is
-5%.
The projected
CAGR
for the next 3 years is
10%.
You don't have any saved screeners yet
